Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sesquiterpenes | 2 | 2023 | 176 | 1.520 |
Why?
|
Oligonucleotide Array Sequence Analysis | 21 | 2015 | 3775 | 1.470 |
Why?
|
BRCA1 Protein | 8 | 2024 | 1147 | 1.440 |
Why?
|
BRCA2 Protein | 7 | 2024 | 798 | 1.350 |
Why?
|
Chromosomal Instability | 12 | 2020 | 177 | 1.290 |
Why?
|
Protein Kinase C | 24 | 2022 | 1199 | 1.150 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 8 | 2022 | 1088 | 1.020 |
Why?
|
Gene Expression Profiling | 25 | 2021 | 9411 | 0.970 |
Why?
|
Antigens, Neoplasm | 6 | 2022 | 1998 | 0.860 |
Why?
|
Isoenzymes | 19 | 1998 | 1690 | 0.820 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2024 | 2276 | 0.790 |
Why?
|
Mutation | 32 | 2024 | 29932 | 0.790 |
Why?
|
Templates, Genetic | 1 | 2021 | 189 | 0.780 |
Why?
|
Neoplasms | 28 | 2024 | 22072 | 0.740 |
Why?
|
Thrombocytosis | 2 | 2017 | 82 | 0.690 |
Why?
|
Cytological Techniques | 1 | 2021 | 218 | 0.680 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3616 | 0.670 |
Why?
|
Carcinoma, Renal Cell | 9 | 2023 | 3218 | 0.660 |
Why?
|
Antineoplastic Agents | 18 | 2023 | 13630 | 0.660 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2021 | 8515 | 0.660 |
Why?
|
Phorbol Esters | 10 | 1996 | 108 | 0.660 |
Why?
|
Breast Neoplasms | 28 | 2024 | 21025 | 0.650 |
Why?
|
DNA Probes | 4 | 2009 | 551 | 0.640 |
Why?
|
DNA, Complementary | 5 | 2006 | 1991 | 0.610 |
Why?
|
Genetic Heterogeneity | 10 | 2019 | 724 | 0.600 |
Why?
|
Kidney Neoplasms | 9 | 2023 | 4312 | 0.600 |
Why?
|
DNA Repair | 10 | 2023 | 2039 | 0.580 |
Why?
|
Artifacts | 2 | 2021 | 1898 | 0.570 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 155 | 0.520 |
Why?
|
DNA Damage | 7 | 2024 | 2442 | 0.490 |
Why?
|
Tetradecanoylphorbol Acetate | 11 | 1998 | 818 | 0.490 |
Why?
|
ras Proteins | 2 | 2017 | 1052 | 0.480 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1007 | 0.460 |
Why?
|
Sequence Analysis, DNA | 7 | 2021 | 4713 | 0.450 |
Why?
|
Loss of Heterozygosity | 5 | 2021 | 659 | 0.440 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 2 | 2023 | 106 | 0.400 |
Why?
|
Cisplatin | 6 | 2020 | 1644 | 0.400 |
Why?
|
Lactones | 7 | 1996 | 319 | 0.390 |
Why?
|
DNA Mutational Analysis | 7 | 2021 | 4107 | 0.380 |
Why?
|
Evolution, Molecular | 7 | 2020 | 1885 | 0.380 |
Why?
|
Exosomes | 1 | 2016 | 424 | 0.380 |
Why?
|
Esophageal Neoplasms | 2 | 2021 | 1648 | 0.370 |
Why?
|
Ovarian Neoplasms | 6 | 2021 | 4878 | 0.370 |
Why?
|
Lung Neoplasms | 13 | 2023 | 13262 | 0.370 |
Why?
|
Models, Statistical | 3 | 2021 | 5075 | 0.360 |
Why?
|
Gene Expression | 9 | 2015 | 7588 | 0.360 |
Why?
|
Immunotherapy | 6 | 2023 | 4642 | 0.360 |
Why?
|
Genes, Neoplasm | 3 | 2021 | 370 | 0.320 |
Why?
|
Online Systems | 1 | 2009 | 181 | 0.320 |
Why?
|
Prostatic Neoplasms | 6 | 2023 | 11345 | 0.320 |
Why?
|
Algorithms | 10 | 2024 | 13981 | 0.300 |
Why?
|
Computational Biology | 8 | 2021 | 3505 | 0.300 |
Why?
|
Keratinocytes | 5 | 1996 | 792 | 0.300 |
Why?
|
Protein Kinase C-alpha | 6 | 2022 | 113 | 0.290 |
Why?
|
Humans | 120 | 2024 | 760621 | 0.290 |
Why?
|
Prognosis | 22 | 2021 | 29658 | 0.290 |
Why?
|
Mutagens | 2 | 2019 | 178 | 0.280 |
Why?
|
Hybridization, Genetic | 1 | 2006 | 103 | 0.270 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2023 | 4550 | 0.260 |
Why?
|
Mutagenesis | 5 | 2022 | 1234 | 0.250 |
Why?
|
Sequence Alignment | 1 | 2009 | 2176 | 0.250 |
Why?
|
Neoplasm Metastasis | 7 | 2020 | 4902 | 0.250 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 16939 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2828 | 0.250 |
Why?
|
Tumor Microenvironment | 6 | 2023 | 3844 | 0.240 |
Why?
|
Receptors, Estrogen | 7 | 2011 | 2210 | 0.240 |
Why?
|
DNA, Neoplasm | 3 | 2021 | 1745 | 0.240 |
Why?
|
Aneuploidy | 3 | 2006 | 551 | 0.240 |
Why?
|
Genetic Markers | 2 | 2013 | 2608 | 0.240 |
Why?
|
Tumor Cells, Cultured | 11 | 2021 | 6131 | 0.230 |
Why?
|
Mucoepidermoid Tumor | 1 | 2023 | 1 | 0.230 |
Why?
|
Allelic Imbalance | 2 | 2016 | 77 | 0.230 |
Why?
|
Genes, BRCA2 | 5 | 2023 | 603 | 0.220 |
Why?
|
Platelet Count | 2 | 2017 | 777 | 0.220 |
Why?
|
Gene Targeting | 1 | 2006 | 839 | 0.210 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2023 | 5253 | 0.210 |
Why?
|
Ataxia Telangiectasia | 1 | 2023 | 107 | 0.210 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6315 | 0.210 |
Why?
|
Claudins | 1 | 2023 | 115 | 0.210 |
Why?
|
Reproducibility of Results | 12 | 2021 | 20080 | 0.210 |
Why?
|
Databases, Genetic | 3 | 2021 | 1738 | 0.210 |
Why?
|
DNA Copy Number Variations | 6 | 2020 | 2013 | 0.200 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2014 | 412 | 0.200 |
Why?
|
Neoplasm Staging | 9 | 2024 | 11152 | 0.200 |
Why?
|
Gene Conversion | 1 | 2022 | 67 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2023 | 15789 | 0.200 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 36 | 0.190 |
Why?
|
Models, Genetic | 7 | 2021 | 3442 | 0.190 |
Why?
|
Desmosomes | 1 | 2001 | 72 | 0.190 |
Why?
|
Receptor, erbB-2 | 7 | 2011 | 2554 | 0.190 |
Why?
|
TATA Box | 1 | 2001 | 127 | 0.190 |
Why?
|
Viral Tail Proteins | 1 | 2020 | 4 | 0.190 |
Why?
|
Gene Dosage | 5 | 2018 | 1218 | 0.190 |
Why?
|
RNA | 3 | 2006 | 2722 | 0.180 |
Why?
|
Cells | 1 | 2002 | 164 | 0.180 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2023 | 262 | 0.180 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5251 | 0.180 |
Why?
|
Human Genome Project | 1 | 2001 | 199 | 0.180 |
Why?
|
Breast | 4 | 2018 | 1963 | 0.180 |
Why?
|
Poly I-C | 1 | 2020 | 112 | 0.180 |
Why?
|
Serine | 1 | 2024 | 830 | 0.180 |
Why?
|
Replication Protein A | 1 | 2020 | 52 | 0.180 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2023 | 545 | 0.180 |
Why?
|
Point Mutation | 5 | 2020 | 1594 | 0.180 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2020 | 824 | 0.180 |
Why?
|
Toll-Like Receptor 3 | 1 | 2020 | 98 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2024 | 1351 | 0.170 |
Why?
|
Biological Evolution | 1 | 2006 | 1074 | 0.170 |
Why?
|
Bryostatins | 7 | 1996 | 24 | 0.170 |
Why?
|
Prions | 1 | 2001 | 179 | 0.170 |
Why?
|
Brain Neoplasms | 2 | 2018 | 8986 | 0.170 |
Why?
|
Endogenous Retroviruses | 1 | 2020 | 111 | 0.170 |
Why?
|
Genes, cdc | 1 | 2019 | 115 | 0.170 |
Why?
|
Antigen Presentation | 2 | 2022 | 1254 | 0.170 |
Why?
|
Adoptive Transfer | 1 | 2022 | 822 | 0.160 |
Why?
|
Signal Transduction | 12 | 2022 | 23376 | 0.160 |
Why?
|
Female | 56 | 2024 | 391270 | 0.160 |
Why?
|
Receptors, IgE | 6 | 1999 | 372 | 0.160 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1078 | 0.160 |
Why?
|
DNA Replication | 3 | 2022 | 1412 | 0.160 |
Why?
|
Gene Amplification | 2 | 2015 | 1085 | 0.150 |
Why?
|
Gene Expression Regulation | 5 | 2010 | 11903 | 0.150 |
Why?
|
Macrolides | 7 | 1996 | 206 | 0.150 |
Why?
|
RecQ Helicases | 1 | 2018 | 53 | 0.150 |
Why?
|
Computer Simulation | 3 | 2017 | 6218 | 0.150 |
Why?
|
Telomere | 2 | 2016 | 933 | 0.150 |
Why?
|
Platinum Compounds | 1 | 2018 | 95 | 0.150 |
Why?
|
Cytotoxins | 2 | 2016 | 153 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2022 | 1355 | 0.150 |
Why?
|
Protein Folding | 1 | 2001 | 867 | 0.150 |
Why?
|
Genes, BRCA1 | 4 | 2016 | 765 | 0.150 |
Why?
|
Bacteriophages | 1 | 2020 | 372 | 0.140 |
Why?
|
Melanoma | 3 | 2022 | 5697 | 0.140 |
Why?
|
Genomic Imprinting | 1 | 2019 | 330 | 0.140 |
Why?
|
Indazoles | 1 | 2018 | 302 | 0.140 |
Why?
|
src-Family Kinases | 2 | 1998 | 535 | 0.140 |
Why?
|
Gene Library | 2 | 1999 | 1060 | 0.140 |
Why?
|
Cadherins | 1 | 2001 | 898 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2019 | 717 | 0.140 |
Why?
|
Interferon-gamma | 2 | 2022 | 3157 | 0.140 |
Why?
|
Tumor Escape | 1 | 2019 | 370 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2017 | 2943 | 0.130 |
Why?
|
Ornithine Decarboxylase | 3 | 1992 | 64 | 0.130 |
Why?
|
Genes, MHC Class I | 1 | 2016 | 240 | 0.130 |
Why?
|
Neoadjuvant Therapy | 4 | 2017 | 2821 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1046 | 0.130 |
Why?
|
Blood Proteins | 1 | 2021 | 1173 | 0.130 |
Why?
|
Cell Cycle | 4 | 2020 | 2934 | 0.130 |
Why?
|
Tyrosine | 3 | 1998 | 1438 | 0.120 |
Why?
|
Biopsy | 6 | 2017 | 6771 | 0.120 |
Why?
|
Disease-Free Survival | 6 | 2019 | 6828 | 0.120 |
Why?
|
Vaccination | 2 | 2024 | 3361 | 0.120 |
Why?
|
Protein Kinase C-delta | 6 | 1998 | 114 | 0.120 |
Why?
|
Receptors, Drug | 1 | 1994 | 157 | 0.120 |
Why?
|
Chickens | 4 | 2019 | 860 | 0.120 |
Why?
|
Cytosine | 1 | 2015 | 212 | 0.120 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10181 | 0.120 |
Why?
|
Zinc Fingers | 1 | 1996 | 568 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2022 | 1889 | 0.120 |
Why?
|
Drug Resistance, Multiple | 3 | 2011 | 254 | 0.120 |
Why?
|
Ligands | 2 | 2020 | 3276 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2015 | 187 | 0.110 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2015 | 263 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2022 | 5496 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2015 | 2698 | 0.110 |
Why?
|
Aged | 19 | 2024 | 169152 | 0.110 |
Why?
|
RNA, Neoplasm | 3 | 2005 | 749 | 0.110 |
Why?
|
Esophagectomy | 1 | 2017 | 466 | 0.110 |
Why?
|
Models, Biological | 4 | 2012 | 9467 | 0.110 |
Why?
|
Colorectal Neoplasms | 4 | 2020 | 6853 | 0.110 |
Why?
|
Chromosomes, Human | 1 | 2015 | 442 | 0.110 |
Why?
|
Animals | 42 | 2023 | 167963 | 0.110 |
Why?
|
Genomic Instability | 2 | 2014 | 704 | 0.110 |
Why?
|
Immunoassay | 1 | 2016 | 746 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 3610 | 0.100 |
Why?
|
Melanoma, Experimental | 1 | 1996 | 562 | 0.100 |
Why?
|
Papilloma | 1 | 1993 | 141 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2022 | 2566 | 0.100 |
Why?
|
Middle Aged | 20 | 2024 | 220352 | 0.100 |
Why?
|
Antigens | 3 | 2016 | 1447 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.100 |
Why?
|
Amino Acids | 1 | 2018 | 1714 | 0.100 |
Why?
|
Oncogene Proteins | 2 | 2020 | 719 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2017 | 9276 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2015 | 2717 | 0.100 |
Why?
|
Phylogeny | 4 | 2018 | 2775 | 0.090 |
Why?
|
Male | 28 | 2024 | 359744 | 0.090 |
Why?
|
Phenotype | 8 | 2021 | 16546 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2919 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2021 | 4357 | 0.090 |
Why?
|
Clone Cells | 4 | 2020 | 1660 | 0.090 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 678 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 944 | 0.090 |
Why?
|
RNA Interference | 2 | 2010 | 2846 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4573 | 0.090 |
Why?
|
Mast Cells | 5 | 1999 | 1390 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2001 | 3707 | 0.090 |
Why?
|
Receptors, Formyl Peptide | 2 | 2021 | 146 | 0.090 |
Why?
|
Disease Progression | 5 | 2018 | 13502 | 0.090 |
Why?
|
Preoperative Care | 1 | 2019 | 2256 | 0.090 |
Why?
|
Piperidines | 1 | 2018 | 1650 | 0.090 |
Why?
|
Oligopeptides | 1 | 1995 | 1187 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58995 | 0.090 |
Why?
|
Genome | 2 | 2016 | 1739 | 0.090 |
Why?
|
Mice | 21 | 2023 | 81208 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.080 |
Why?
|
Cohort Studies | 6 | 2024 | 41335 | 0.080 |
Why?
|
Crohn Disease | 1 | 2022 | 2275 | 0.080 |
Why?
|
Software | 3 | 2017 | 4419 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1728 | 0.080 |
Why?
|
Databases, Factual | 2 | 2008 | 8035 | 0.080 |
Why?
|
3T3 Cells | 3 | 1996 | 1085 | 0.080 |
Why?
|
Base Sequence | 6 | 2014 | 12446 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4353 | 0.080 |
Why?
|
Skin | 3 | 1992 | 4466 | 0.080 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 929 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11712 | 0.080 |
Why?
|
Yeasts | 1 | 2009 | 279 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1895 | 0.080 |
Why?
|
Genome, Human | 4 | 2021 | 4417 | 0.080 |
Why?
|
Sirolimus | 2 | 2013 | 1547 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5643 | 0.080 |
Why?
|
Edema | 2 | 1992 | 769 | 0.080 |
Why?
|
Sensitivity and Specificity | 5 | 2011 | 14660 | 0.080 |
Why?
|
Cell Lineage | 1 | 2017 | 2533 | 0.080 |
Why?
|
Ploidies | 3 | 2014 | 275 | 0.070 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1994 | 866 | 0.070 |
Why?
|
Computer Graphics | 1 | 2009 | 341 | 0.070 |
Why?
|
Down-Regulation | 5 | 2001 | 2913 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2882 | 0.070 |
Why?
|
Genetic Variation | 3 | 2021 | 6551 | 0.070 |
Why?
|
DNA Primers | 4 | 2001 | 2819 | 0.070 |
Why?
|
Capsaicin | 4 | 1991 | 231 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2011 | 580 | 0.070 |
Why?
|
Organ Specificity | 3 | 2021 | 1955 | 0.070 |
Why?
|
Cell Line | 9 | 2019 | 15620 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 6544 | 0.070 |
Why?
|
Normal Distribution | 2 | 2021 | 273 | 0.070 |
Why?
|
Metagenomics | 1 | 2010 | 457 | 0.070 |
Why?
|
Cell Survival | 5 | 2021 | 5797 | 0.070 |
Why?
|
Diterpenes | 3 | 1991 | 171 | 0.070 |
Why?
|
Adult | 13 | 2021 | 219994 | 0.070 |
Why?
|
Skin Neoplasms | 3 | 2014 | 5799 | 0.060 |
Why?
|
Taxoids | 1 | 2009 | 669 | 0.060 |
Why?
|
Nerve Net | 1 | 1998 | 2261 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2017 | 3486 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2008 | 956 | 0.060 |
Why?
|
Paclitaxel | 2 | 2010 | 1736 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12531 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 15289 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1898 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1613 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1130 | 0.060 |
Why?
|
Diglycerides | 2 | 1996 | 176 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 4 | 2021 | 17790 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2101 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 1998 | 1173 | 0.060 |
Why?
|
RNA, Messenger | 7 | 2012 | 12766 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3529 | 0.060 |
Why?
|
Enzyme Activation | 6 | 1999 | 3602 | 0.060 |
Why?
|
Genomics | 5 | 2021 | 5794 | 0.060 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2020 | 452 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1004 | 0.060 |
Why?
|
Glycoside Hydrolases | 1 | 2024 | 132 | 0.060 |
Why?
|
Epigenomics | 2 | 2023 | 936 | 0.060 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 618 | 0.060 |
Why?
|
Genetic Diseases, Inborn | 1 | 2008 | 601 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2020 | 3442 | 0.060 |
Why?
|
Alleles | 3 | 2023 | 6898 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2023 | 11071 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.060 |
Why?
|
Kinetics | 6 | 1997 | 6377 | 0.060 |
Why?
|
Autophagy | 1 | 2011 | 1337 | 0.060 |
Why?
|
Phosphorylation | 7 | 2020 | 8313 | 0.060 |
Why?
|
Transcription Factors | 4 | 2015 | 12103 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3568 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2004 | 196 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5351 | 0.050 |
Why?
|
Germ-Line Mutation | 3 | 2021 | 1841 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2005 | 2696 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9185 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 161 | 0.050 |
Why?
|
Enzyme Induction | 2 | 1994 | 452 | 0.050 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3758 | 0.050 |
Why?
|
Cell Membrane Permeability | 4 | 1998 | 575 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2009 | 6068 | 0.050 |
Why?
|
Drug Antagonism | 2 | 1992 | 52 | 0.050 |
Why?
|
Janus Kinase 1 | 1 | 2022 | 107 | 0.050 |
Why?
|
ran GTP-Binding Protein | 1 | 2002 | 51 | 0.050 |
Why?
|
Polyploidy | 2 | 2014 | 119 | 0.050 |
Why?
|
Biological Transport | 3 | 1998 | 2086 | 0.050 |
Why?
|
DNA Helicases | 2 | 2020 | 854 | 0.050 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1122 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2418 | 0.050 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2021 | 17 | 0.050 |
Why?
|
Ribonuclease H | 1 | 2022 | 50 | 0.050 |
Why?
|
Feedback, Physiological | 1 | 2004 | 476 | 0.050 |
Why?
|
Molecular Sequence Data | 6 | 1999 | 17624 | 0.050 |
Why?
|
Carcinogens | 2 | 2014 | 449 | 0.050 |
Why?
|
Desmocollins | 1 | 2001 | 11 | 0.050 |
Why?
|
Chromosome Aberrations | 3 | 2013 | 1764 | 0.050 |
Why?
|
DNA Contamination | 1 | 2021 | 18 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2023 | 428 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2022 | 101 | 0.050 |
Why?
|
DNA Adducts | 1 | 2022 | 94 | 0.050 |
Why?
|
Integrin alpha Chains | 1 | 2021 | 95 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 450 | 0.050 |
Why?
|
Acetylation | 1 | 2023 | 1062 | 0.050 |
Why?
|
Monitoring, Immunologic | 1 | 2020 | 98 | 0.040 |
Why?
|
Oncogenes | 2 | 2021 | 1220 | 0.040 |
Why?
|
Hyperplasia | 3 | 1992 | 1155 | 0.040 |
Why?
|
Time Factors | 5 | 2015 | 40165 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 155 | 0.040 |
Why?
|
H-2 Antigens | 1 | 2020 | 358 | 0.040 |
Why?
|
Glioblastoma | 1 | 2015 | 3484 | 0.040 |
Why?
|
Rad51 Recombinase | 1 | 2020 | 188 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2864 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2020 | 397 | 0.040 |
Why?
|
Blotting, Northern | 1 | 2001 | 1543 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1433 | 0.040 |
Why?
|
Ceramides | 2 | 2011 | 201 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2023 | 9530 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2016 | 18957 | 0.040 |
Why?
|
Enzyme Precursors | 1 | 1999 | 174 | 0.040 |
Why?
|
Leukemia, Basophilic, Acute | 2 | 1995 | 15 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2020 | 410 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2021 | 324 | 0.040 |
Why?
|
Hydroxyurea | 1 | 2020 | 282 | 0.040 |
Why?
|
Apyrase | 1 | 2021 | 373 | 0.040 |
Why?
|
Threonine | 1 | 1999 | 272 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1855 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 429 | 0.040 |
Why?
|
Sample Size | 1 | 2002 | 840 | 0.040 |
Why?
|
Cross Reactions | 1 | 2020 | 818 | 0.040 |
Why?
|
Protein Kinase C-epsilon | 2 | 1994 | 43 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.040 |
Why?
|
Logic | 1 | 1998 | 42 | 0.040 |
Why?
|
Phosphotyrosine | 2 | 1995 | 456 | 0.040 |
Why?
|
Protein Interaction Mapping | 1 | 2021 | 617 | 0.040 |
Why?
|
Treatment Outcome | 8 | 2022 | 65017 | 0.040 |
Why?
|
Multigene Family | 1 | 2001 | 1077 | 0.040 |
Why?
|
Stochastic Processes | 1 | 1999 | 354 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 80372 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 1995 | 6216 | 0.040 |
Why?
|
Internet | 1 | 2009 | 3078 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2024 | 800 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2021 | 1342 | 0.040 |
Why?
|
Gene Deletion | 2 | 2015 | 2668 | 0.040 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2017 | 81 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2018 | 315 | 0.040 |
Why?
|
Intercellular Junctions | 1 | 1997 | 197 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2018 | 256 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2018 | 385 | 0.030 |
Why?
|
Interleukin-3 | 1 | 1998 | 425 | 0.030 |
Why?
|
Rats | 11 | 1999 | 23711 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4283 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 307 | 0.030 |
Why?
|
Limit of Detection | 1 | 2017 | 280 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 1996 | 327 | 0.030 |
Why?
|
Protein Transport | 1 | 2002 | 1964 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2006 | 2176 | 0.030 |
Why?
|
Cell Tracking | 1 | 2017 | 138 | 0.030 |
Why?
|
Tight Junctions | 1 | 1998 | 315 | 0.030 |
Why?
|
4-Butyrolactone | 1 | 1996 | 62 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 820 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 1999 | 13451 | 0.030 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2016 | 132 | 0.030 |
Why?
|
Ubiquitination | 1 | 2020 | 1008 | 0.030 |
Why?
|
Hungary | 1 | 2015 | 82 | 0.030 |
Why?
|
Protein Binding | 3 | 2017 | 9335 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 146 | 0.030 |
Why?
|
Epithelial Cells | 3 | 2004 | 3663 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54303 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2011 | 2506 | 0.030 |
Why?
|
Molecular Structure | 2 | 1996 | 1895 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 575 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 165 | 0.030 |
Why?
|
Cell Fusion | 1 | 2015 | 293 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2798 | 0.030 |
Why?
|
Brain | 3 | 2018 | 26951 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1403 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1994 | 189 | 0.030 |
Why?
|
Substrate Specificity | 2 | 1995 | 1792 | 0.030 |
Why?
|
Platinum | 1 | 2016 | 223 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2221 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1995 | 370 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2010 | 7850 | 0.030 |
Why?
|
Exons | 2 | 2011 | 2388 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2536 | 0.030 |
Why?
|
DNA Methylation | 2 | 2024 | 4373 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 1995 | 202 | 0.030 |
Why?
|
Basophils | 2 | 1994 | 404 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2015 | 468 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1994 | 384 | 0.030 |
Why?
|
Feces | 1 | 2020 | 1455 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2503 | 0.030 |
Why?
|
Mitogens | 1 | 1994 | 230 | 0.030 |
Why?
|
Blotting, Western | 1 | 2001 | 5039 | 0.030 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 1993 | 58 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2021 | 5870 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 1995 | 10827 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1588 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1996 | 459 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 367 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14495 | 0.030 |
Why?
|
Genetic Engineering | 1 | 1999 | 933 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 746 | 0.030 |
Why?
|
Glioma | 1 | 2008 | 3420 | 0.030 |
Why?
|
Calcium | 3 | 1997 | 5725 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2014 | 245 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1994 | 915 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15697 | 0.030 |
Why?
|
Risk Factors | 5 | 2019 | 74359 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2017 | 1493 | 0.030 |
Why?
|
Probability | 1 | 1998 | 2475 | 0.030 |
Why?
|
Dermatitis, Contact | 1 | 1992 | 133 | 0.030 |
Why?
|
Cell Division | 2 | 1998 | 4463 | 0.030 |
Why?
|
Mitosis Modulators | 1 | 2011 | 1 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2016 | 1089 | 0.020 |
Why?
|
Dacarbazine | 1 | 2015 | 560 | 0.020 |
Why?
|
Ganglia, Spinal | 2 | 1991 | 523 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2001 | 2440 | 0.020 |
Why?
|
Binding Sites | 3 | 1997 | 6048 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 652 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2011 | 52 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18137 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
Plants, Medicinal | 1 | 1992 | 166 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2938 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6360 | 0.020 |
Why?
|
Transfection | 4 | 2004 | 5781 | 0.020 |
Why?
|
Exocytosis | 1 | 1993 | 319 | 0.020 |
Why?
|
Cytosol | 1 | 1994 | 887 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5785 | 0.020 |
Why?
|
Nucleosomes | 1 | 2015 | 484 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2016 | 983 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2015 | 715 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 1407 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2015 | 556 | 0.020 |
Why?
|
Keratins | 1 | 1992 | 497 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1895 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2015 | 727 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 1994 | 3084 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1995 | 788 | 0.020 |
Why?
|
Antigens, CD | 1 | 2021 | 4000 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1697 | 0.020 |
Why?
|
Postoperative Care | 1 | 2017 | 1479 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1091 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
Body Water | 1 | 1991 | 341 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1832 | 0.020 |
Why?
|
Research | 1 | 1998 | 1974 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1818 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
Recombinant Proteins | 5 | 1998 | 6538 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4742 | 0.020 |
Why?
|
Afferent Pathways | 1 | 1991 | 299 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2803 | 0.020 |
Why?
|
Neurotoxins | 1 | 1991 | 240 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1115 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2010 | 573 | 0.020 |
Why?
|
Peroxidase | 1 | 1992 | 605 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1810 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 995 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2014 | 1388 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12159 | 0.020 |
Why?
|
Epithelium | 1 | 2013 | 1605 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2008 | 162 | 0.020 |
Why?
|
PubMed | 1 | 2008 | 128 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2009 | 204 | 0.020 |
Why?
|
Neurons, Afferent | 1 | 1990 | 498 | 0.020 |
Why?
|
LLC-PK1 Cells | 2 | 1998 | 125 | 0.020 |
Why?
|
Immunoblotting | 3 | 1998 | 1649 | 0.020 |
Why?
|
Disorders of Sex Development | 1 | 2008 | 128 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3817 | 0.020 |
Why?
|
Genes, p53 | 1 | 2010 | 713 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2015 | 1596 | 0.020 |
Why?
|
Peptides | 2 | 2016 | 4354 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12626 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2022 | 10446 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14372 | 0.020 |
Why?
|
Adipocytes | 1 | 2013 | 1179 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2618 | 0.020 |
Why?
|
Tamoxifen | 1 | 2010 | 963 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2010 | 9585 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
Rats, Inbred Strains | 3 | 1991 | 2094 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18416 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12965 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4166 | 0.020 |
Why?
|
Testis | 1 | 2008 | 794 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1990 | 2672 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1993 | 4899 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 1513 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1999 | 1693 | 0.020 |
Why?
|
DNA | 1 | 1998 | 7233 | 0.020 |
Why?
|
Mitosis | 1 | 2010 | 1191 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1741 | 0.010 |
Why?
|
Histones | 1 | 2015 | 2583 | 0.010 |
Why?
|
Lung | 1 | 2023 | 9994 | 0.010 |
Why?
|
DNA, Antisense | 1 | 2004 | 44 | 0.010 |
Why?
|
Engineering | 1 | 2004 | 56 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1994 | 2825 | 0.010 |
Why?
|
Ovary | 1 | 2008 | 958 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3301 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2006 | 848 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2056 | 0.010 |
Why?
|
Quality Control | 1 | 2006 | 828 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.010 |
Why?
|
Fibroblasts | 1 | 1994 | 4090 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1722 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4024 | 0.010 |
Why?
|
Microtubules | 1 | 2009 | 1072 | 0.010 |
Why?
|
Mammaplasty | 1 | 2013 | 1240 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3202 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10182 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1994 | 4490 | 0.010 |
Why?
|
Apoptosis | 1 | 1998 | 9501 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1994 | 4938 | 0.010 |
Why?
|
Dinoprostone | 1 | 2004 | 598 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2011 | 1423 | 0.010 |
Why?
|
Proteins | 1 | 1995 | 6029 | 0.010 |
Why?
|
Cell Differentiation | 2 | 1995 | 11481 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.010 |
Why?
|
Immunoglobulin E | 2 | 1996 | 1484 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2004 | 611 | 0.010 |
Why?
|
Freeze Fracturing | 1 | 1998 | 68 | 0.010 |
Why?
|
Vanadates | 1 | 1998 | 82 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5877 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1998 | 169 | 0.010 |
Why?
|
Equipment Design | 1 | 2006 | 3520 | 0.010 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 1998 | 145 | 0.010 |
Why?
|
Tetracycline | 1 | 1998 | 220 | 0.010 |
Why?
|
Swine | 2 | 1998 | 5899 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9073 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8482 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12808 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7064 | 0.010 |
Why?
|
Upstream Stimulatory Factors | 1 | 1996 | 18 | 0.010 |
Why?
|
Thionucleotides | 1 | 1996 | 112 | 0.010 |
Why?
|
Daunorubicin | 1 | 1995 | 156 | 0.010 |
Why?
|
Pain | 1 | 1991 | 5066 | 0.010 |
Why?
|
Rhodamines | 1 | 1995 | 179 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2753 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5791 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2558 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1996 | 617 | 0.010 |
Why?
|
HIV-1 | 1 | 1992 | 6849 | 0.010 |
Why?
|
Alanine | 1 | 1997 | 606 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 1995 | 221 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1996 | 548 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1998 | 886 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1996 | 1142 | 0.010 |
Why?
|
Vinblastine | 1 | 1995 | 487 | 0.010 |
Why?
|
Cell Membrane | 2 | 1995 | 3682 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1995 | 532 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 1996 | 3765 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1994 | 285 | 0.010 |
Why?
|
Bacteria | 1 | 2004 | 2199 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2869 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1996 | 695 | 0.010 |
Why?
|
Baculoviridae | 1 | 1993 | 115 | 0.010 |
Why?
|
Independent State of Samoa | 1 | 1992 | 2 | 0.010 |
Why?
|
Lysine | 1 | 1997 | 1001 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1995 | 1628 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1992 | 151 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1994 | 586 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10344 | 0.010 |
Why?
|
Neurons | 1 | 1991 | 9426 | 0.010 |
Why?
|
Membranes | 1 | 1990 | 165 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 1993 | 573 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39261 | 0.010 |
Why?
|
Cats | 1 | 1990 | 976 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2873 | 0.010 |
Why?
|
Heart Rate | 2 | 1991 | 4179 | 0.010 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1990 | 314 | 0.000 |
Why?
|
Young Adult | 1 | 2014 | 58741 | 0.000 |
Why?
|
Capillary Permeability | 1 | 1990 | 768 | 0.000 |
Why?
|
Drug Interactions | 1 | 1991 | 1428 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 87810 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1998 | 3387 | 0.000 |
Why?
|
Neuropeptides | 1 | 1990 | 943 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1995 | 3726 | 0.000 |
Why?
|
Virus Replication | 1 | 1992 | 2432 | 0.000 |
Why?
|
Hot Temperature | 1 | 1991 | 1435 | 0.000 |
Why?
|
Respiration | 1 | 1990 | 1654 | 0.000 |
Why?
|
Monocytes | 1 | 1992 | 2575 | 0.000 |
Why?
|
United States | 1 | 2006 | 72461 | 0.000 |
Why?
|
Blood Pressure | 1 | 1990 | 8525 | 0.000 |
Why?
|